Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Talbot

Showing results (191-200 of 255) with videos related to

Pageof 26
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
Targeted BDNF upregulation via upstream open reading frame disruptionNing Feng, Thomas Goedert, Nenad Svrzikapa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 11, 2024
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlatesCarolyn A Young, Amina Chaouch, Christopher J Mcdermott, et al.
Annals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.
Nature Communications|November 26, 2021
Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteinsTopaz Altman, Ariel Ionescu, Amjad Ibraheem, et al.
Human Mutation|October 20, 2011
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N)Heather M McLaughlin, Reiko Sakaguchi, William Giblin, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
Neurobiology of Disease|August 18, 2020
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stressEmily Feneberg, David Gordon, Alexander G Thompson, et al.
Scientific Reports|January 25, 2017
Whole-exome sequencing of 228 patients with sporadic Parkinson's diseaseCynthia Sandor, Frantisek Honti, Wilfried Haerty, et al.
Human Mutation|August 30, 2012
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivoAimée Vester, Gisselle Velez-Ruiz, Heather M McLaughlin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 23, 2019
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron diseaseCarolyn Anne Young, John Ealing, Christopher McDermott, et al.
Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
Targeted BDNF upregulation via upstream open reading frame disruptionNing Feng, Thomas Goedert, Nenad Svrzikapa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 11, 2024
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlatesCarolyn A Young, Amina Chaouch, Christopher J Mcdermott, et al.
Annals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.
Nature Communications|November 26, 2021
Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteinsTopaz Altman, Ariel Ionescu, Amjad Ibraheem, et al.
Human Mutation|October 20, 2011
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N)Heather M McLaughlin, Reiko Sakaguchi, William Giblin, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
Neurobiology of Disease|August 18, 2020
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stressEmily Feneberg, David Gordon, Alexander G Thompson, et al.
Scientific Reports|January 25, 2017
Whole-exome sequencing of 228 patients with sporadic Parkinson's diseaseCynthia Sandor, Frantisek Honti, Wilfried Haerty, et al.
Human Mutation|August 30, 2012
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivoAimée Vester, Gisselle Velez-Ruiz, Heather M McLaughlin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 23, 2019
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron diseaseCarolyn Anne Young, John Ealing, Christopher McDermott, et al.
Pageof 26